Rangan GK - Search Results

1

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Pharmacological Management.

Mallett A, Lee VW, Mai J, Lopez-Vargas P, Rangan GK. Mallett A, et al. Among authors: rangan gk. Semin Nephrol. 2015 Nov;35(6):582-589.e17. doi: 10.1016/j.semnephrol.2015.10.009. Semin Nephrol. 2015. PMID: 26718162 Review. No abstract available.

2

Adriamycin nephropathy in severe combined immunodeficient (SCID) mice.

Lee VW, Wang Y, Qin X, Wang Y, Zheng G, Mahajan D, Coombes J, Rangan G, Alexander SI, Harris DC. Lee VW, et al. Nephrol Dial Transplant. 2006 Nov;21(11):3293-8. doi: 10.1093/ndt/gfl413. Epub 2006 Aug 5. Nephrol Dial Transplant. 2006. PMID: 16891644 No abstract available.

3

Polycystic kidney disease: Progression of polycystic kidney disease--a lack of progress?

McDonald S, Rangan G. McDonald S, et al. Nat Rev Nephrol. 2014 Sep;10(9):489-91. doi: 10.1038/nrneph.2014.138. Epub 2014 Aug 5. Nat Rev Nephrol. 2014. PMID: 25092149 No abstract available.

4

Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.

Tong A, Tunnicliffe DJ, Lopez-Vargas P, Mallett A, Patel C, Savige J, Campbell K, Patel M, Tchan MC, Alexander SI, Lee V, Craig JC, Fassett R, Rangan GK. Tong A, et al. Among authors: rangan gk. Nephrology (Carlton). 2016 Feb;21(2):122-32. doi: 10.1111/nep.12579. Nephrology (Carlton). 2016. PMID: 26235729

5

A protocol for the identification and validation of novel genetic causes of kidney disease.

Mallett A, Patel C, Maier B, McGaughran J, Gabbett M, Takasato M, Cameron A, Trnka P, Alexander SI, Rangan G, Tchan MC, Caruana G, John G, Quinlan C, McCarthy HJ, Hyland V, Hoy WE, Wolvetang E, Taft R, Simons C, Healy H, Little M. Mallett A, et al. BMC Nephrol. 2015 Sep 15;16:152. doi: 10.1186/s12882-015-0148-8. BMC Nephrol. 2015. PMID: 26374634 Free PMC article.

6

KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.

Rangan GK, Alexander SI, Campbell KL, Dexter MA, Lee VW, Lopez-Vargas P, Mai J, Mallett A, Patel C, Patel M, Tchan MC, Tong A, Tunnicliffe DJ, Vladica P, Savige J. Rangan GK, et al. Nephrology (Carlton). 2016 Aug;21(8):705-16. doi: 10.1111/nep.12658. Nephrology (Carlton). 2016. PMID: 26511892 Review. No abstract available.

7

Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells.

Ta MH, Liuwantara D, Rangan GK. Ta MH, et al. Among authors: rangan gk. BMC Nephrol. 2015 Dec 15;16:212. doi: 10.1186/s12882-015-0193-3. BMC Nephrol. 2015. PMID: 26666710 Free PMC article.

8

Introduction to the KHA-CARI Guidelines on ADPKD.

Rangan GK, Savige J. Rangan GK, et al. Semin Nephrol. 2015 Nov;35(6):521-3. doi: 10.1016/j.semnephrol.2015.10.001. Semin Nephrol. 2015. PMID: 26718154 No abstract available.

9

Autosomal Dominant Polycystic Kidney Disease: A Path Forward.

Rangan GK, Lopez-Vargas P, Nankivell BJ, Tchan M, Tong A, Tunnicliffe DJ, Savige J. Rangan GK, et al. Semin Nephrol. 2015 Nov;35(6):524-37. doi: 10.1016/j.semnephrol.2015.10.002. Semin Nephrol. 2015. PMID: 26718155 Review.

10

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis.

Tchan M, Savige J, Patel C, Mallett A, Tong A, Tunnicliffe DJ, Rangan GK. Tchan M, et al. Among authors: rangan gk. Semin Nephrol. 2015 Nov;35(6):545-549.e2. doi: 10.1016/j.semnephrol.2015.10.007. Semin Nephrol. 2015. PMID: 26718157 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page